Renovus Capital Partners Forms Life Sciences Commercialization Platform by Merging MC3 and Curtis Learning

July 13, 2022

Renovus Capital Partners has created a new life sciences commercialization platform through a majority investment and merger of MC3 and Curtis Learning. The combined company brings together MC3's meeting production and virtual delivery technology with Curtis Learning's scientific training expertise to scale services for pharmaceutical and biotech clients.

Buyers
Renovus Capital Partners
Targets
MC3, Curtis Learning
Location
Pennsylvania, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.